Study: Coronav vaccine will provide immunity for at least three months
Researchers at the US National Institute of Allergy and Infectious Diseases (NIAID) have studied the response of 34 adults, both young and old, from the first stage of the clinical trials. In an article in the New England Journal of Medicine, they write that the antibodies decrease slowly over time, but they were still elevated … Read more